Mitochondrial degeneration is considered to play an important role in the development of diabetic peripheral neuropathy in humans. Mitochondrial degeneration and the corresponding protein regulation associated with the degeneration were studied in an animal model of diabetic neuropathy. PGC-1α and its-regulated transcription factors including TFAM and NRF1, which are master regulators of mitochondrial biogenesis, are significantly downregulated in streptozotocin diabetic dorsal root ganglion (DRG) neurons. Diabetic mice develop peripheral neuropathy, loss of mitochondria, decreased mitochondrial DNA content and increased protein oxidation. Importantly, this phenotype is exacerbated in PGC-1α (−/−) diabetic mice, which develop a more severe neuropathy with reduced mitochondrial DNA and a further increase in protein oxidation. PGC-1α (−/−) diabetic mice develop an increase in total cholesterol and triglycerides, and a decrease in TFAM and NRF1 protein levels. Loss of PGC-1α causes severe mitochondrial degeneration with vacuolization in DRG neurons, coupled with reduced state 3 and 4 respiration, reduced expression of oxidative stress response genes and an increase in protein oxidation. In contrast, overexpression of PGC-1α in cultured adult mouse neurons prevents oxidative stress associated with increased glucose levels. The study provides new insights into the role of PGC-1α in mitochondrial regeneration in peripheral neurons and suggests that therapeutic modulation of PGC-1α function may be an attractive approach for treatment of diabetic neuropathy.
Introduction
Diabetes-induced-oxidative damage in neurons, axons, and Schwann cells has been proposed as a unifying mechanism for diabetic neuropathy (Anjaneyulu et al., 2008; Christianson et al., 2003; Coppey et al., 2006; He et al., 2002; Ho et al., 2006; Kishi et al., 2002; Obrosova, 2002; Obrosova et al., 2005; Russell et al., 2008; Sasaki et al., 1997; Song et al., 2003; Vincent et al., 2004; Vincent et al., 2006; Yagihashi et al., 2001) . One mechanism for generation of oxidative stress is that an increased metabolic influx into mitochondria (Mt) increases respiration and results in a high proton gradient, leading to increased production of reactive oxygen species (ROS). Consistent with this notion, there is an increase in Mt inner membrane depolarization and degeneration of Mt in diabetic neuropathy (Huang et al., 2003; Kishi et al., 2002; Russell et al., 2002; Vincent et al., 2004) . These impaired Mt may be rescued by the activation of Mt biogenesis or regeneration of new Mt. Thus, activation of Mt biogenesis may be protective under conditions where significant Mt degeneration is present.
Peroxisome proliferator-activated receptor-gamma co-activator 1α (PGC-1α) is a transcriptional co-activator and a master regulator for Mt biogenesis in many tissues including the nervous system (Lehman et al., 2000; Lin et al., 2002; Puigserver et al., 1998; St Pierre et al., 2006) . PGC-1α is a promising target for therapy for neurological disease. For example, the pan-PPAR agonist, bezafibrate, upregulates PGC-1α and exerts beneficial effects in a transgenic mouse model of Huntington's disease (Johri et al., 2012) . PGC-1α activates transcriptional factors such as nuclear respiratory factor 1 (NRF1) and Mt transcription factor A (TFAM), which in turn induce Mt respiration proteins and lead to replication of the Mt genome (Kelly and Scarpulla, 2004; Puigserver and Spiegelman, 2003; Wu et al., 1999) . PGC-1α has been mapped to chromosome 4P15.1, a region associated with basal insulin levels in Pima Indians that are at high risk of developing diabetes and diabetic related complications (Esterbauer et al., 1999) . Furthermore, common polymorphisms of PGC-1α are associated with conversion from
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